Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
published : This year symbols : Bntx save search
DADA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Dada Nexus Limited Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Published: 2024-01-18 (Crawled : 09:00) - prnewswire.com
CMI | $287.56 -1.33% 0.0% 2.6M
|
Producer Manufacturing
|
| O: -0.13%
H: 0.59%
C: 0.18%
DADA | $1.86 1.09% 1.08% 600K
|
Technology Services
|
| O: 1.33%
H: 21.05%
C: 18.42%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 0.19%
H: 0.2%
C: -0.27%
CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4) Inhibitors Market to grow by USD 2.23 billion between 2023 and 2028, growth Driven by High target affinity and specificity of CTLA4 inhibitors - Technavio
Published: 2024-01-26 (Crawled : 02:00) - prnewswire.com
XLO | $1.16 -9.38% -10.34% 340K
|
Professional, Scientific, and T...
|
| O: 4.69%
H: 4.55%
C: -2.99%
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 2.92%
H: 1.06%
C: -3.05%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -1.35%
H: 0.12%
C: -0.83%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 1.07%
H: 0.1%
C: -0.94%
AGEN | $5.3 6.64% 6.23% 1.5M
|
Health Technology
|
| O: 3.13%
H: 11.02%
C: 7.11%
protein growth market
BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidates at AACR 2024
Published: 2024-03-11 (Crawled : 12:00) - globenewswire.com
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -0.19%
H: 7.03%
C: 5.71%
EAF INVESTOR NOTIFICATION: Kessler Topaz Meltzer & Check, LLP Announces Lead Plaintiff Deadline on March 25, 2024 in Securities Fraud Class Action Lawsuit Filed against GrafTech International Ltd.
Published: 2024-03-12 (Crawled : 01:00) - prnewswire.com
EAF | $1.51 2.03% 0.0% 3.6M
|
Producer Manufacturing
|
| O: -0.56%
H: 8.38%
C: 4.47%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 0.54%
H: 0.18%
C: -1.13%
international deadline
BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
Published: 2024-03-20 (Crawled : 11:00) - biospace.com/
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -5.51%
H: 1.33%
C: 1.2%
AUTL | $4.51 -6.04% -6.43% 1.4M
|
Health Technology
|
| O: 1.45%
H: 5.33%
C: 4.13%
year update financial results
Final Deadline Approaching for Mercury Systems, Inc. Investors: Kessler Topaz Meltzer & Check, LLP Reminds Mercury Systems, Inc. (MRCY) Investors of February 12, 2024 Lead Plaintiff Deadline
Published: 2024-02-08 (Crawled : 20:00) - prnewswire.com
MBLY | $30.21 -2.49% -2.55% 2.2M
|
|
| O: 1.13%
H: 4.71%
C: 3.63%
MRCY | $27.99 -1.13% -1.14% 390K
|
Electronic Technology
|
| O: 0.88%
H: 10.92%
C: 10.73%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -0.11%
H: 0.0%
C: -0.91%
deadline mercury
BIVI Investors Have Opportunity to Lead BioVie Inc. Securities Fraud Lawsuit
Published: 2024-03-05 (Crawled : 16:00) - prnewswire.com
NOVA | $3.8 0.53% 0.0% 10M
|
Distribution Services
|
| O: -1.59%
H: 0.44%
C: -9.43%
BIVI | $0.4874 -0.21% -0.21% 490K
|
Health Technology
|
| O: -2.82%
H: 1.45%
C: -12.78%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -1.18%
H: 3.4%
C: 2.57%
Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates
Published: 2024-03-14 (Crawled : 11:00) - globenewswire.com
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 0.11%
H: 0.3%
C: -1.21%
AUTL | $4.51 -6.04% -6.43% 1.4M
|
Health Technology
|
| O: 1.82%
H: 12.19%
C: 2.15%
business year therapeutics financial results
Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against BioNTech SE
Published: 2024-01-21 (Crawled : 00:00) - prnewswire.com
CMI | $287.56 -1.33% 0.0% 2.6M
|
Producer Manufacturing
|
| O: 0.13%
H: 2.2%
C: 1.91%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 0.17%
H: 1.54%
C: 1.44%
BNTX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that BioNTech SE Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Published: 2024-01-22 (Crawled : 08:00) - prnewswire.com
MBLY | $30.21 -2.49% -2.55% 2.2M
|
|
| O: 2.33%
H: 2.79%
C: -0.38%
FTFT | $0.86 -3.59% -3.72% 24K
|
Consumer Non-Durables
|
| O: -1.88%
H: 4.86%
C: -1.54%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 0.17%
H: 1.54%
C: 1.44%
BioNTech and DualityBio Initiate Pivotal Phase 3 Trial Of Antibody-Drug Conjugate Candidate BNT323/DB-1303 in Metastatic Breast Cancer
Published: 2024-01-22 (Crawled : 12:00) - globenewswire.com
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 0.17%
H: 1.54%
C: 1.44%
bnt323 candidate breast cancer trial
Pomerantz LLP Announces Notice of Pendency of Class Action and Proposed Settlement of Class Action in the In re iAnthus Capital Holdings, Inc. Securities Litigation
Published: 2024-01-22 (Crawled : 15:00) - prnewswire.com
ITHUF | $0.0176 -10.56% 7.1K
|
Process Industries
|
| O: -18.81%
H: 25.0%
C: 25.0%
ABR | $12.62 1.12% 0.24% 3.1M
|
Finance
|
| O: 0.82%
H: 0.0%
C: 0.0%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 0.17%
H: 1.54%
C: 1.44%
BioNTech SE (BNTX) Shareholder Reminder: Kessler Topaz Meltzer & Check, LLP Reminds BNTX Investors of Securities Fraud Class Action Lawsuit Filed On Their Behalf
Published: 2024-01-30 (Crawled : 21:00) - prnewswire.com
CMI | $287.56 -1.33% 0.0% 2.6M
|
Producer Manufacturing
|
| O: -0.01%
H: 0.05%
C: -1.43%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -1.03%
H: 2.91%
C: 1.11%
BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjugate Candidate BNT325/DB-1305
Published: 2024-01-31 (Crawled : 12:00) - globenewswire.com
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -1.03%
H: 2.91%
C: 1.11%
bnt325 fda candidate designation
BTI Investors Have Opportunity to Lead British American Tobacco p.l.c. Securities Fraud Lawsuit
Published: 2024-02-20 (Crawled : 15:00) - prnewswire.com
MBLY | $30.21 -2.49% -2.55% 2.2M
|
|
| O: -0.12%
H: 0.31%
C: -1.25%
BTAFF | $28.176 44.6% 1.8K
|
Consumer Non-Durables
|
| O: 1.78%
H: 0.47%
C: -1.11%
BTI | $29.05 0.8% -0.07% 5.6M
|
Consumer Non-Durables
|
| O: -1.54%
H: 1.12%
C: 0.9%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -1.28%
H: 2.34%
C: 0.82%
Kessler Topaz Meltzer & Check, LLP Reminds Assertio Holdings, Inc. Investors of Important Deadline in Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm
Published: 2024-01-23 (Crawled : 02:00) - prnewswire.com
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -0.11%
H: 0.66%
C: 0.59%
ASRT | $0.7625 1.13% 1.11% 890K
|
Health Technology
|
| O: 0.91%
H: 0.0%
C: -3.91%
deadline
CMI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cummins Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
Published: 2024-01-23 (Crawled : 08:00) - prnewswire.com
MBLY | $30.21 -2.49% -2.55% 2.2M
|
|
| O: 1.83%
H: 0.17%
C: -3.37%
CMI | $287.56 -1.33% 0.0% 2.6M
|
Producer Manufacturing
|
| O: 0.7%
H: 1.38%
C: 0.29%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -0.11%
H: 0.66%
C: 0.59%
Attention BNTX Shareholders: Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Securities Fraud Class Action Lawsuit Filed against BioNTech SE (BNTX) and Encourages Investors to Contact the Firm
Published: 2024-02-26 (Crawled : 15:30) - prnewswire.com
MBLY | $30.21 -2.49% -2.55% 2.2M
|
|
| O: 0.29%
H: 4.93%
C: 2.39%
CMI | $287.56 -1.33% 0.0% 2.6M
|
Producer Manufacturing
|
| O: 0.01%
H: 1.06%
C: 0.84%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -1.03%
H: 1.27%
C: 0.56%
Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against GrafTech International Ltd.
Published: 2024-02-05 (Crawled : 01:00) - prnewswire.com
EAF | $1.51 2.03% 0.0% 3.6M
|
Producer Manufacturing
|
| O: 1.53%
H: 1.5%
C: -6.77%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 1.32%
H: 0.0%
C: -0.55%
ASRT | $0.7625 1.13% 1.11% 890K
|
Health Technology
|
| O: 0.0%
H: 2.64%
C: 0.41%
international
BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
Published: 2024-03-20 (Crawled : 10:00) - globenewswire.com
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -1.37%
H: 0.0%
C: -1.58%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.62%
H: 0.45%
C: 0.34%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: -5.51%
H: 1.33%
C: 1.2%
management commercial
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.